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Abstract: 
 
The central aim of this thesis is to investigate how physicians, working for 
Pharmaceutical Product Development (PPD), a clinical research organisation (CRO), 
make decisions for a new industry standard for good clinical practice in medical 
device trials. This topic is introduced via review of decision theory and decision-
making (DM) in contextual environments. Physician’s career experiences, insights 
and perceptions of how they make regulatory compliance decisions, and how they 
think these new requirements should be met, are explored in the main study. 
 
The research rationale relates to the author’s experience of physician DM in non-
medical settings during 25 years working in the field, with a desire to ascertain how 
compliance influences are identified, assessed and synthesized into decisions within 
the workplace. Furthermore PPD physicians hold senior positions and new industry 
regulations require regulatory compliance decisions to be made at the highest level. 
 
In this study an interpretive phenomenological paradigm was used to ascertain how 
physicians make sense of industry regulation then make compliance decisions 
based on their roles, experiences, cues and sources of data available. Literature 
review identified 4 core themes (decision-making, errors, situation awareness and 
new requirements) that guided qualitative data collection via 2 mini-focus groups 
(n=3 per group) and semi-structured interviews (n=12). Review of 18 physicians’ 
data occurred via framework analysis then comparing between contrasting positions 
presented. The findings found 4-5 dimensions under each core theme from which 2 
frameworks were constructed: firstly, using DM tenets to guide physicians’ DM in 
context and, secondly, identifying how to comply with new industry requirements.  
 
This research contributes to academia and practice via framework generation for DM 
in context. It is unique in its contextual exploration, analysis and interpretation of 
physicians’ impressions, from departmental heads to company board members, in 
relation to their everyday working lives and the decision approaches used to ensure 
regulatory compliance within their organisational area of responsibility. The thesis 
ends by considering potential areas for further research such as deploying each 
framework, applying the framework concepts with other industry legislation changes 
or exploring alternative research paradigms in PPD. 
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